CAS No. : 66389-74-0

Product Details
For research use only. Not Intended for Therapeutic Use!
Cat No:I004498
Molecular Formula:C28H30O6
Molecular Weight:462.53
Target:Bcl-2 Family
IC50:0.5- 2 uM [1]
Price:Get quote
We match the lowest price on market.

Your information is safe with us.

Cat No:I004498
Cas No:66389-74-0

(+)-Apogossypol(Apogossypol; NSC736630) is a potent inhibitor of Bcl-2 family proteins; competing with the BH3 peptide-binding sites on Bcl-2, Bcl-XL, Mcl-1, Bcl-W, and Bcl-B, but not Bfl-1, with IC50s of 0.5 to 2 μM.
IC50 value: 0.5- 2 uM [1]
Target: Bcl-2 inhibitor
in vitro: Bcl-2-expressing B cells from transgenic mice were more sensitive to cytotoxicity induced by apogossypol than gossypol, with LD50 values of 3 to 5 microM and 7.5 to 10 microM, respectively [1].
in vivo: Using the maximum tolerated dose of gossypol for sequential daily dosing, apogossypol displayed superior activity to gossypol in terms of reducing splenomegaly and reducing B-cell counts in spleens of Bcl-2-transgenic mice [1]. Apogossypol is capable of binding and inhibiting Bcl-2 and Bcl-X(L) with high affinity and induces apoptosis of tumor cell lines [2].

[1]. Kitada S, et al. Bcl-2 antagonist apogossypol (NSC736630) displays single-agent activity in Bcl-2-transgenic mice and has superior efficacy with less toxicity compared with gossypol (NSC19048). Blood. 2008 Mar 15;111(6):3211-9.
[2]. Becattini B, et al. Rational design and real time, in-cell detection of the proapoptotic activity of a novel compound targeting Bcl-X(L). Chem Biol. 2004 Mar;11(3):389-95.

Related Products
  • CAS No. :886578-07-0
    Product Name:


    Cat No: R018850 View details
  • CAS No. :335166-36-4
    Product Name:


    Cat No: I011474 View details
  • CAS No. :
    Product Name:

    BIM, Biotinylated

    Cat No: P000232 View details
  • CAS No. :509102-00-5
    Product Name:


    Cat No: I003814 View details